Bizarre Patents
Hands free towel carrying system
A hands free towel carrying system for coupling a towel to a user to prevent loss, theft or contamination.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5846952 | Methods and compositions for poly-ଲ-1-4-N-acetylglucosamine drug delivery The present invention relates to a purified, easily produced poly-ଲ-1.fwdarw.4-N-acetylglucosamine (p-GlcNAc) polysaccharide species useful in drug compositions. The p-GlcNAc of the invention is a polymer of high molecular weight whose constituent m... | 12/08/1998 |
| 5693620 | Plasmalopsychosines and plasmalocerebrosides An isolated plasmalopsychosine selected from the group consisting of compound A and compound B: ##STR1## wherein n1 is 0-50 or an isolated synthetic plasmalocerebroside selected from the group consisting of compound C and compound D: ##STR2## ... | 12/02/1997 |
| 5686115 | Poly-ଲ-1.fwdarw.4-N-acetylucosamine copolymer composition with collagen The present invention relates to a purified, easily produced poly-ଲ-1.fwdarw.4-N-acetylglucosamine (p-GlcNAc) polysaccharide species useful in collagen copolymers. The p-GlcNAc of the invention is a polymer of high molecular weight whose constituent... | 11/11/1997 |
| 5658880 | Sialic acid/fucose based medicaments Compounds that exhibit selectin binding activity are described and have the following structural formula: ##STR1## where W is selected from a group including structures a-d below ##STR2## wherein p is an integer of from 0-2, q is an integer of f... | 08/19/1997 |
| 5654282 | Selectin binding glycopeptides Glyco-amino acids and glycopeptides having three-dimensionally stable configurations are described. These glyco-amino acids and glycopeptides have glycoside functional groups, such as fucose and analogues and derivatives thereof, covalently bound to an am... | 08/05/1997 |
| 5652221 | Method of treating defective glucose metabolism using synthetic insulin substances A synthetic insulin mimetic compound is disclosed. Small synthetic amines of disaccharides, such as 2-deoxy-2-amino-galactopyranosyl pinitol are shown to mimic the action of insulin and to modulate its action.... | 07/29/1997 |
| 5646129 | Method of using low molecular weight hyaluronic acid for stimulating bone formation The present invention is drawn to hyaluronic acid fractions having molecular weights in the range of from about 20,000 to about 60,000 daltons, wherein these hyaluronic acid fractions possess osteoinductive activity. The present invention further includes... | 07/08/1997 |
| 5646131 | Method for solubilizing drugs using cyclodextrins and carboxylic acids A method for enhancing the solubilization and/or complexation of a drug which is insoluble or sparingly soluble in water with cyclodextrin, comprising combining the drug with cyclodextrin together with a selected hydroxy-carboxylic or polycarboxylic acid.... | 07/08/1997 |
| 5644049 | Biomaterial comprising hyaluronic acid and derivatives thereof in interpenetrating polymer networks (IPN) Provided is a biomaterial comprising an interpenetrating polymer network (IPN), wherein one of the polymer components is an acidic polysaccharide or a semi-synthetic derivative thereof. The polysaccharide can be hyaluronic acid, and the second polymer com... | 07/01/1997 |
| 5639734 | Disaccharide inflammation inhibitors and uses thereof The present invention provides a composition of matter comprising a biosynthetic anti-inflammatory oligosaccharide, comprising the structure of: sugar - sugar - X - R; wherein said sugar is selected from the group consisting of N-acetylneuraminic acid, ga... | 06/17/1997 |
| 5639738 | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs A method of treating a mammal for a condition of the skin or exposed tissue selected from the group consisting of basal cell carcinoma and actinic keratosis is provided. The method consists essentially of topically administering to the site of the conditi... | 06/17/1997 |
| 5635493 | Methods and compositions for poly-ଲ-1-4-N-acetylglucosamine chemotherapeutics The present invention relates to a purified, easily produced poly-ଲ-1.fwdarw.4-N-acetylglucosamine (p-GlcNAc) polysaccharide species useful in drug compositions. The p-GlcNAc of the invention is a polymer of high molecular weight whose constituent m... | 06/03/1997 |
| 5633368 | Partially acylated ଲ-cyclodextrins Partially acylated cyclodextrins of the formula I ##STR1## where R denotes hydrogen or R1, wherein R1 can be identical or different and denotes acetyl, propionyl, butyryl, 2-alkoxyacetyl, 2-chloroacetyl, 2-fluoroacetyl, 2-N-acetylaminoacetyl, methacr... | 05/27/1997 |
| 5633357 | Synthesis of carboxylic acid glucuronides A method of producing a carboxylic acid glucuronide by reacting a carboxylic acid precursor with a blocked sugar epoxide precursor is disclosed. Also disclosed are: deuterated 11-nor-Ɗ8 - or Ɗ9 -THC carboxylic acid glucuronide havi... | 05/27/1997 |
| 5631241 | Pharmaceutical compositions containing hyaluronic acid fractions Two pharmaceutically useful fractions of hyaluronic acid are obtained comprising a first fraction with a molecular weight between 50,000 and 100,000 which is useful for wound healing, and a second fraction having a molecular weight between 500,000 and 730... | 05/20/1997 |
| 5624839 | Process for culturing hepatocytes for formation of spheroids Hepatocytes spheroids can be formed by culturing hepatocytes in a culture vessel using a lipid-bound glycosaminoglycan as a culture substrate. Floating spheroids of hepatocytes can be obtained efficiently, which are capable of maintaining liver-specific f... | 04/29/1997 |
| 5624679 | Methods and compositions for poly-ଲ-1-4-N-acetylglucosamine biological barriers The present invention relates to a purified, easily produced poly-ଲ-1.fwdarw.4-N-acetylglucosamine (p-GlcNAc) polysaccharide species. The p-GlcNAc of the invention is a polymer of high molecular weight whose constituent monosaccharide sugars are att... | 04/29/1997 |
| 5622834 | Method of isolating poly-ଲ-1-4-N-acetylglucosamine from microalgal culture The present invention relates to a purified, easily produced poly-ଲ-1.fwdarw.4-N-acetylglucosamine (p-GlcNAc) polysaccharide species. The p-GlcNAc of the invention is a polymer of high molecular weight whose constituent monosaccharide sugars are att... | 04/22/1997 |
| 5622937 | Compositions and methods of inhibiting the binding of E-selectin or P-selectin or sialyl-Lewisx or sialyl-Lewisa This invention relates to compounds that inhibit the binding of E-selectin or P-selectin to sialyl-Lewisx or sialyl-Lewisa presented on a cell surface having the general structure: ##STR1## This invention also relates to methods... | 04/22/1997 |
| 5623064 | Poly-ଲ-1.fwdarw.-4-N-acetylglucosamine The present invention relates to a purified, easily produced poly-ଲ-1.fwdarw.4-N-acetylglucosamine (p-GlcNAc) polysaccharide species. The p-GlcNAc of the invention is a polymer of high molecular weight whose constituent monosaccharide sugars are att... | 04/22/1997 |
| 5622936 | Tumor inhibiting saccharide conjugates The invention relates to a method for the preparation of glycoconjugates of phosphorus amides with the general formula ##STR1## where the connection of the sugar with the phosphoric acid amide mustard residue, and the ifosfamide mustard residue, resp... | 04/22/1997 |
| 5620858 | Method of removing shiga-like toxins from biological samples Diagnostic and therapeutic compositions which comprise the Gal(1-4)ଲGal subunit are described. These compositions permit the rapid diagnosis and treatment of enteric infections caused by E. coli that produce shiga-like toxins (SLT).... | 04/15/1997 |
| 5621086 | Sialic acid derivative and method of manufacturing it The present invention is drawn to methods of manufacturing a sialic acid derivative suitable for industrial production. With a method of the present invention, Tetra-O-acetylsialic acid (4a) and acetylcytidine-5'-O-amidite (5a) are condensed in the presen... | 04/15/1997 |
| 5614615 | Sialyl Lewis X mimetics incorporating fucopeptides Sialyl Lewis X mimetics incorporating fucopeptides are synthesized and shown to mimic the configuration and essential functional groups of sialyl Lewis X in space. The fucopeptides exhibit substantially the same biological activity as sialyl Lewis X in th... | 03/25/1997 |
| 5612321 | Antioxidant grafted polysaccharides Grafted polysaccharide compositions comprising polysaccharides grafted with antioxidants on at least one hydroxyl group of the polysaccharide. The use of antioxidant grafted polysaccharides or antioxidant grafted crosslinked polysaccharides as a treatment... | 03/18/1997 |
| 5605893 | Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients A therapeutic food composition for treatment of diabetic patients to diminish fluctuations in blood sugar levels and prevent hypoglycemic episodes, comprising per unit about 20-50 grams of nutrients including a slowly absorbed or digested complex carbohyd... | 02/25/1997 |
| 5605892 | Compositions of arginine amide with cyclodextrin of caffeine, and methods of use An aqueous agent comprising at least one arginine amide selected from the group consisting of (2R,4R)-4-methyl-1-[N2 -((RS)-3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-arginyl]-2-piper idinecarboxylic acid, monohydrate thereof and pharmac... | 02/25/1997 |
| 5604207 | Sialyl Lex analogues as inhibitors of cellular adhesion The inventive compounds are analogues of sialyl Lex that inhibit cellular adhesion between a selectin and cells that express sialyl Lex on their surfaces, and their synthetic intermediates. An inventive compound has structure A, ... | 02/18/1997 |
| 5601799 | Partially delipidated D25 polysaccaride composition for imaging and diagnosis The present invention relates to a D 25 polysaccharide compound whose lipid has been partially removed and to its derivatives, wherein at least 85% by weight, preferably 90% of the compound, exists in aqueous solution in monomeric form. The 30 kD molecula... | 02/11/1997 |
| 5599916 | Chitosan salts having improved absorbent properties and process for the preparation thereof Disclosed is a method for producing a water-swellable, water-insoluble chitosan salt having improved absorption properties. The method involves forming a mixture of a chitosan, water, an acid, and, optionally, a crosslinking agent, recovering the formed c... | 02/04/1997 |
| 5599801 | Purified heparin fractions, method for obtaining them and pharmaceutical compositions containing them Heparin fractions obtained by nitrous depolymerization, containing at most 150 ppb of total N-nitroso compounds, prepared by subjecting heparins of natural origin which have been depolymerized with a nitrite to the action of UV radiation.... | 02/04/1997 |
| 5599915 | Sialyl Lewis X mimetics Sialyl Lewisx mimetic compounds are disclosed that are free of sialyl groups and glycosidically-linked fucosyl groups. These compounds exhibit about the same inhibition of selectin-medicated cellular adhesion as does sialyl Lewisx it... | 02/04/1997 |
| 5593969 | Lipid-A analogs: monosaccharide and dissaccharide compounds for inhibiting binding of lipid A receptors to lipid A receptors A compound of the formula: ##STR1## wherein: each of R1, R1 ', R2 and R2 ' independent of each other is a substituted or unsubstituted, branched or linear C1-12 alkyl, alkene or alkyne group, R | 01/14/1997 |
| 5589465 | Glycolipid derivatives acting as ligands for selectins Novel glycolipid derivatives of Formula (I): ##STR1## wherein R is a long chain alkyl, or their salts are disclosed. These compounds act as a ligand for selectin family and exhibit a remarkable inhibitory effect on the binding of selectin family to i... | 12/31/1996 |
| 5589588 | Sulfated acid amides having anticoagulant properties A sulfated acid amide having heparin-like properties of the formula: (R1)--NH--R--NH--(R1) where R1 is a di-, tri- or tetra-saccharide acid selected from cellobiose, cellotriose, cellotetrose, maltose, maltotriose and maltotetrose o... | 12/31/1996 |
| 5583213 | Process to activate sulfated polysaccharides The present specification is directed to a novel process to prepare an activated sulfated polysaccharide which may then be used in subsequent reactions or processes to bind the reactive polysaccharide with a nucleophilic agent or an aminated surface. The ... | 12/10/1996 |
| 5583208 | Ganglioside GM3 derivatives containing fluorine in ceramide portion A ganglioside GM3 derivative containing fluorine atoms in a ceramide portion thereof, represented by the formula: ##STR1## in which m is an integer of at least 2, n is an integer of 0 to 7 provided that m is larger than n, and R represents an alkyl g... | 12/10/1996 |
| 5583121 | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes A method of treating hypovolemic shock and related shock syndromes by the administration of substantially non-anticoagulant heparinoids without the hemorrhaging problems generally associated with heparin; such syndromes include degradation of the microvas... | 12/10/1996 |
| 5580858 | Immunosuppressive and tolerogenic modified Lewisx compounds Disclosed are novel Lewisx and Lewisa analogues, pharmaceutical compositions containing such analogues, methods for their preparation and methods for their use.... | 12/03/1996 |
| 5576305 | Intercellular adhesion mediators The present invention is directed towards compositions and methods for reducing or controlling inflammation and for treating inflammatory disease processes and other pathological conditions mediated by intercellular adhesion. The compositions of the inven... | 11/19/1996 |
